ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $732,000 | -37.4% | 62,225 | -27.3% | 0.01% | -41.2% |
| Q1 2019 | $1,169,000 | +150.3% | 85,625 | +88.1% | 0.02% | +112.5% |
| Q4 2018 | $467,000 | +13.9% | 45,525 | +84.9% | 0.01% | +33.3% |
| Q3 2018 | $410,000 | +89.8% | 24,625 | +79.7% | 0.01% | +100.0% |
| Q2 2018 | $216,000 | -43.0% | 13,700 | -58.6% | 0.00% | -57.1% |
| Q4 2017 | $379,000 | – | 33,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |